1de7: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
Line 1: Line 1:
[[Image:1de7.jpg|left|200px]]
{{Seed}}
[[Image:1de7.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1de7|  PDB=1de7  |  SCENE=  }}  
{{STRUCTURE_1de7|  PDB=1de7  |  SCENE=  }}  


'''INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA-THROMBIN: CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX'''
===INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA-THROMBIN: CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX===




==Overview==
<!--
The serine protease thrombin proteolytically activates blood coagulation factor XIII by cleavage at residue Arg(37); factor XIII in turn cross-links fibrin molecules and gives mechanical stability to the blood clot. The 2.0-A resolution x-ray crystal structure of human alpha-thrombin bound to the factor XIII-(28-37) decapeptide has been determined. This structure reveals the detailed atomic level interactions between the factor XIII activation peptide and thrombin and provides the first high resolution view of this functionally important part of the factor XIII molecule. A comparison of this structure with the crystal structure of fibrinopeptide A complexed with thrombin highlights several important determinants of thrombin substrate interaction. First, the P1 and P2 residues must be compatible with the geometry and chemistry of the S1 and S2 specificity sites in thrombin. Second, a glycine in the P5 position is necessary for the conserved substrate conformation seen in both factor XIII-(28-37) and fibrinopeptide A. Finally, the hydrophobic residues, which occupy the aryl binding site of thrombin determine the substrate conformation further away from the catalytic residues. In the case of factor XIII-(28-37), the aryl binding site is shared by hydrophobic residues P4 (Val(34)) and P9 (Val(29)). A bulkier residue in either of these sites may alter the substrate peptide conformation.
The line below this paragraph, {{ABSTRACT_PUBMED_10956659}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 10956659 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_10956659}}


==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Factor xiii activation peptide]]
[[Category: Factor xiii activation peptide]]
[[Category: Hydrolase/peptide]]
[[Category: Hydrolase/peptide]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 13:45:06 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 22:53:27 2008''

Revision as of 19:53, 30 June 2008

File:1de7.png

Template:STRUCTURE 1de7

INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA-THROMBIN: CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX

Template:ABSTRACT PUBMED 10956659

About this Structure

1DE7 is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Interaction of the factor XIII activation peptide with alpha -thrombin. Crystal structure of its enzyme-substrate analog complex., Sadasivan C, Yee VC, J Biol Chem. 2000 Nov 24;275(47):36942-8. PMID:10956659

Page seeded by OCA on Mon Jun 30 22:53:27 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=1de7&oldid=587008"